Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Cheng Zhou, Xianchen Jiang, Xiaojun Guan, Tao Guo, Jingjing Wu, Haoting Wu, Chenqing Wu, Jingwen Chen, Jiaqi Wen, Sijia Tan, Xiaojie Duanmu, Jianmei Qin, Weijin Yuan, Qianshi Zheng, Peiyu Huang, Baorong Zhang, Xiaojun Xu, Minming Zhang
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867014524445392897
author Cheng Zhou
Xianchen Jiang
Xiaojun Guan
Tao Guo
Jingjing Wu
Haoting Wu
Chenqing Wu
Jingwen Chen
Jiaqi Wen
Sijia Tan
Xiaojie Duanmu
Jianmei Qin
Weijin Yuan
Qianshi Zheng
Peiyu Huang
Baorong Zhang
Xiaojun Xu
Minming Zhang
author_facet Cheng Zhou
Xianchen Jiang
Xiaojun Guan
Tao Guo
Jingjing Wu
Haoting Wu
Chenqing Wu
Jingwen Chen
Jiaqi Wen
Sijia Tan
Xiaojie Duanmu
Jianmei Qin
Weijin Yuan
Qianshi Zheng
Peiyu Huang
Baorong Zhang
Xiaojun Xu
Minming Zhang
Cheng Zhou
Xianchen Jiang
Xiaojun Guan
Tao Guo
Jingjing Wu
Haoting Wu
Chenqing Wu
Jingwen Chen
Jiaqi Wen
Sijia Tan
Xiaojie Duanmu
Jianmei Qin
Weijin Yuan
Qianshi Zheng
Peiyu Huang
Baorong Zhang
Xiaojun Xu
Minming Zhang
collection Wiley Open Access
contents Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease Cheng Zhou Xianchen Jiang Xiaojun Guan Tao Guo Jingjing Wu Haoting Wu Chenqing Wu Jingwen Chen Jiaqi Wen Sijia Tan Xiaojie Duanmu Jianmei Qin Weijin Yuan Qianshi Zheng Peiyu Huang Baorong Zhang Xiaojun Xu Minming Zhang European Journal of Neurology AbstractBackground and purposeGlymphatic dysfunction may play a significant role in the development of neurodegenerative diseases. We aimed to evaluate the association between glymphatic dysfunction and the risk of malignant event/clinical milestones in Parkinson disease (PD).MethodsThis study included 236 patients from August 2014 to December 2020. Diffusion tensor imaging analysis along the perivascular space (DTI‐ALPS) index was calculated as an approximate measure of glymphatic function. The primary outcomes were four clinical milestones including recurrent falls, wheelchair dependence, dementia, and placement in residential or nursing home care. The associations of DTI‐ALPS with the risk of clinical milestones were examined using multivariate Cox proportional hazards regression models. Then, logistic regression was repeated using clinical variables and DTI‐ALPS index individually and in combination of the two to explore the ability to distinguish patients who reached clinical milestones within a 5‐year period.ResultsA total of 175 PD patients with baseline DTI‐ALPS index and follow‐up clinical assessments were included. A lower DTI‐ALPS was independently associated with increased risk of recurrent falls, wheelchair dependence, and dementia. Additionally, in 103 patients monitored over 5 years, a logistic regression model combining clinical variables and DTI‐ALPS index showed better performance for predicting wheelchair dependence within 5 years than a model using clinical variables or DTI‐ALPS index alone.ConclusionsGlymphatic dysfunction, as measured by the DTI‐ALPS index, was associated with increased risk of clinical milestones in patients with PD. This finding implies that therapy targeting the glymphatic system may serve as a viable strategy for slowing down the progression of PD. 10.1111/ene.16521 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1111/ene.16521
format Artículo Open Access
id wiley_oa_10_1111_ene_16521
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease
Cheng Zhou
Xianchen Jiang
Xiaojun Guan
Tao Guo
Jingjing Wu
Haoting Wu
Chenqing Wu
Jingwen Chen
Jiaqi Wen
Sijia Tan
Xiaojie Duanmu
Jianmei Qin
Weijin Yuan
Qianshi Zheng
Peiyu Huang
Baorong Zhang
Xiaojun Xu
Minming Zhang
European Journal of Neurology
Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease Cheng Zhou Xianchen Jiang Xiaojun Guan Tao Guo Jingjing Wu Haoting Wu Chenqing Wu Jingwen Chen Jiaqi Wen Sijia Tan Xiaojie Duanmu Jianmei Qin Weijin Yuan Qianshi Zheng Peiyu Huang Baorong Zhang Xiaojun Xu Minming Zhang European Journal of Neurology AbstractBackground and purposeGlymphatic dysfunction may play a significant role in the development of neurodegenerative diseases. We aimed to evaluate the association between glymphatic dysfunction and the risk of malignant event/clinical milestones in Parkinson disease (PD).MethodsThis study included 236 patients from August 2014 to December 2020. Diffusion tensor imaging analysis along the perivascular space (DTI‐ALPS) index was calculated as an approximate measure of glymphatic function. The primary outcomes were four clinical milestones including recurrent falls, wheelchair dependence, dementia, and placement in residential or nursing home care. The associations of DTI‐ALPS with the risk of clinical milestones were examined using multivariate Cox proportional hazards regression models. Then, logistic regression was repeated using clinical variables and DTI‐ALPS index individually and in combination of the two to explore the ability to distinguish patients who reached clinical milestones within a 5‐year period.ResultsA total of 175 PD patients with baseline DTI‐ALPS index and follow‐up clinical assessments were included. A lower DTI‐ALPS was independently associated with increased risk of recurrent falls, wheelchair dependence, and dementia. Additionally, in 103 patients monitored over 5 years, a logistic regression model combining clinical variables and DTI‐ALPS index showed better performance for predicting wheelchair dependence within 5 years than a model using clinical variables or DTI‐ALPS index alone.ConclusionsGlymphatic dysfunction, as measured by the DTI‐ALPS index, was associated with increased risk of clinical milestones in patients with PD. This finding implies that therapy targeting the glymphatic system may serve as a viable strategy for slowing down the progression of PD. 10.1111/ene.16521 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease
topic European Journal of Neurology
url https://onlinelibrary.wiley.com/doi/10.1111/ene.16521